Fundz

Embleema, Inc. reported raising $3 Million in an initial SEC Form D filing, from an offering of $3.3 Million

PRIVATEJan 09, 2019$3M of $3.3M raised

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Jan 9, 2019)

Round Type

Seed

BostonInformation TechnologyBiotechnologyHealth Carehospital & health care

Quick answer

Embleema raised $3 Million in a Seed round, dated January 9, 2019. Embleema is based in Boston, Massachusetts, United States.

How much did Embleema raise?
Embleema raised $3 Million in a Seed round on January 9, 2019.
What does Embleema do?
Embleema is a biotechnology company that focuses on innovative solutions for biosurveillance and biosecurity.
Where is Embleema based and how big is it?
Embleema is based in Boston, Massachusetts, United States. Fundz records about 32 employees.

Source: Fundz verified event record.

Who else raised in hospital & health care and Biotechnology around the same time

Companies in the same sectors as Embleema that raised within 45 days of this round, from Fundz verified event records.

  • Climb Bio, Inc. raised $12M on February 19, 2019.
  • SCWorx raised $25M on February 19, 2019.
  • Castle Biosciences raised $8.7M on February 14, 2019.
  • COMPLION INC. raised $6.8M on February 14, 2019.
  • Viracta Therapeutics raised $5.7M on February 12, 2019.
  • Myriad Genetics raised $249K (Pre-Seed) on February 12, 2019.

Who to call at Embleema, and when

A new round usually means Embleema is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Embleema raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Embleema, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Embleema. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Embleema

Location

44 West 28th Street

Boston, Massachusetts, United States

About

Embleema is a biotechnology company that focuses on innovative solutions for biosurveillance and biosecurity. They develop advanced platforms for real-time pathogen detection and analytics. The company leverages FDA-developed technologies to enhance global health surveillance capabilities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Embleema raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Embleema's next move

See what Strategic adds

Embleema raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.